TXNRD1 and cancer: Our results demonstrate that exogenous SELENOV downregulated TXNRD1 and TXNRD3 mRNA expression, which may represent an important anticancer effect since both enzymes are frequent pharmacological targets in various cancer therapies [37,38,39].